earnings per share were $num-one, down num-two% from last year's adjusted $num-three, so firmly exceeding the high end of our february expectation.
net income was $num-one million or $num-two per diluted share, compared to $num-three million or $num-four per diluted share a year ago.
first quarter sales were $num-one million, down num-two% from the prior year period with organic sales declining num-three% as ongoing impacts from the pandemic offset our aerospace end markets.
eps is expected to be in the range of $num-one to $num-two, up num-three% to num-four% from year-five's adjusted earnings of $num-five, that expectation is an increase from our prior view of $num-six to $num-seven, and we expect the first half of the year to contribute approximately num-eight% of year-six's earnings.
we now expect organic sales to be up num-one% to num-two% for the year, an increase from our prior view of up num-three% to num-four%, driven by stronger industrial growth.
compared to a year ago, adjusted operating margin was down num-one bps from num-two%.
we now expect capex to be approximately $num-one million, down $num-two million, average diluted shares of num-three million and cash conversion of over num-four% are consistent with our prior outlook.